DK0435153T3 - R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, fremgangsmåde til dens fremstilling og lægemidler med indhold deraf - Google Patents

R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, fremgangsmåde til dens fremstilling og lægemidler med indhold deraf

Info

Publication number
DK0435153T3
DK0435153T3 DK90124747.8T DK90124747T DK0435153T3 DK 0435153 T3 DK0435153 T3 DK 0435153T3 DK 90124747 T DK90124747 T DK 90124747T DK 0435153 T3 DK0435153 T3 DK 0435153T3
Authority
DK
Denmark
Prior art keywords
propylxanthine
hydroxyhexyl
methyl
preparation
drugs containing
Prior art date
Application number
DK90124747.8T
Other languages
Danish (da)
English (en)
Inventor
Harald Dr Furrer
Ulrich Dr Gebert
Karl Dr Rudolphi
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0435153T3 publication Critical patent/DK0435153T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK90124747.8T 1989-12-23 1990-12-19 R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, fremgangsmåde til dens fremstilling og lægemidler med indhold deraf DK0435153T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3942871A DE3942871A1 (de) 1989-12-23 1989-12-23 R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DK0435153T3 true DK0435153T3 (da) 1996-08-05

Family

ID=6396380

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90124747.8T DK0435153T3 (da) 1989-12-23 1990-12-19 R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, fremgangsmåde til dens fremstilling og lægemidler med indhold deraf

Country Status (9)

Country Link
US (2) US5407815A (cs)
EP (1) EP0435153B1 (cs)
JP (1) JPH07107063B2 (cs)
KR (1) KR0179654B1 (cs)
AT (1) ATE137237T1 (cs)
DE (2) DE3942871A1 (cs)
DK (1) DK0435153T3 (cs)
ES (1) ES2086359T3 (cs)
GR (1) GR3019860T3 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW209834B (cs) * 1991-12-11 1993-07-21 Hoechst Ag
US5648357A (en) * 1992-03-04 1997-07-15 Cell Therapeutics, Inc. Enatiomerically pure hydroxylated xanthine compounds
US5580873A (en) * 1992-03-04 1996-12-03 Cell Therapeutics, Inc. Enatiomerically pure hydroxylated xanthine compounds to treat proliferative vascular diseases
PT584347E (pt) * 1992-03-04 2003-06-30 Cell Therapeutics Inc Compostos de xantina hidroxilados enantiomericos
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
EP1277764A3 (en) * 1992-12-31 2003-01-29 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from dog dander and uses therefor
AU6092794A (en) * 1993-01-19 1994-08-15 Cell Therapeutics, Inc. Oxime-substituted therapeutic compounds
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US9085788B2 (en) 2010-09-01 2015-07-21 Concert Pharmaceuticals, Inc. Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
WO2012031073A1 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2335170C2 (de) * 1973-07-11 1989-07-20 Hoechst Ag, 6230 Frankfurt 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4576947A (en) * 1967-12-16 1986-03-18 Hoechst Aktiengesellschaft Pharmaceutical compositions
US4515795A (en) * 1968-11-25 1985-05-07 Hoechst Aktiengesellschaft Pharmaceutical compositions
DE2366527C2 (cs) * 1973-07-11 1987-08-27 Hoechst Ag, 6230 Frankfurt, De
US4517795A (en) * 1979-11-28 1985-05-21 Deere & Company Bale-shape gauge for baler for forming cylindrical bales
US4857468A (en) * 1985-04-13 1989-08-15 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing optically active 2-halo-1-phenyl ethanol
DK649787A (da) * 1986-12-23 1988-06-24 Hoffmann La Roche Fremgangsmaade til fremstilling af optisk aktive smoersyrederivater
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen

Also Published As

Publication number Publication date
EP0435153A2 (de) 1991-07-03
ES2086359T3 (es) 1996-07-01
EP0435153A3 (en) 1992-05-13
EP0435153B1 (de) 1996-04-24
KR910011854A (ko) 1991-08-07
JPH07107063B2 (ja) 1995-11-15
US5478831A (en) 1995-12-26
DE3942871C2 (cs) 1992-11-05
DE3942871A1 (de) 1991-06-27
ATE137237T1 (de) 1996-05-15
DE59010302D1 (de) 1996-05-30
US5407815A (en) 1995-04-18
KR0179654B1 (ko) 1999-03-20
GR3019860T3 (en) 1996-08-31
JPH04210688A (ja) 1992-07-31

Similar Documents

Publication Publication Date Title
HU896762D0 (en) Process for preparation of pyrimidine-derivatives and for manufacturing of pharmaceutical compositions containing these compounds
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
DK108888D0 (da) Farmaceutisk tablet, farmaceutisk granulat og fremgangsmaader til fremstilling af henholdsvis denne tablet og dette granulat
DK217188A (da) Farmaceutisk praeparat til behandling af neurologiske sygdomme
KR920701466A (ko) 면역조절 장애 치료를 위한 제약학적 생성물
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
DK0435153T3 (da) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, fremgangsmåde til dens fremstilling og lægemidler med indhold deraf
DK579185D0 (da) Pyrrolobenzimidazoler, fremgangsmaade til fremstilling heraf samt laegemidler med indhold heraf
NO881643L (no) Fremgangsmaate for fremstilling av hoeystabile mykgelatinkapsler for terapeutiske formaal.
EP0204989A3 (en) Use of penicillamine in the treatment of immune deficiency diseases
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
NO881190D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 9- (beta-d-deoxyribofuranosyl)-mucleosider.
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
NO880292D0 (no) Fremgangsmaate for behandling av humle.
DK162048C (da) 4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
NO883219D0 (no) Framgangsmaate for framstilling av beta-lactam-forbindelse, mellomprodukt for framstilling av denne, og medisinske sammensetninger for behandling av bakteriologiske infeksjonssykdommer inneholdende denne.
DK65691A (da) 2-aminocarboxylsyre-derivater, deres fremstilling og anvendelse som laegemidler
NO884635L (no) Fremgangsmaate for behandling av voerter.
OA09832A (en) Pharmaceutical composition for the treatment of protozoal diseases particularly of trypanosomiasis, comprising D-carnitrine or acyl derivative of D-carnitine.
IT8741690A0 (it) Farmaco per la profilassi e per la cura delle disbatteriosi vaginali.
IT8021263A0 (it) Dispositivo di sospensione per la cura di fratture del volto medio.